<DOC>
	<DOC>NCT00785460</DOC>
	<brief_summary>Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation of the brachial artery.</brief_summary>
	<brief_title>Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers</brief_title>
	<detailed_description>Benfotiamine pretreatment (3 days)at high dosage (1050 mg/day) prevents in healthy subjects smoking-induced vascular dysfunction assessed by ultrasound flow mediated dilatation (FMD) of the brachial arteryand laboratory parameters (adhesion molecules).</detailed_description>
	<mesh_term>Benphothiamine</mesh_term>
	<criteria>healthy habitual smokers any kind of chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>